Targeting the Oxytocinergic System: A Possible Pharmacological Strategy for the Treatment of Inflammation Occurring in Different Chronic Diseases

Unresolved inflammation represents a central feature of different human pathologies including neuropsychiatric, cardiovascular, and metabolic diseases. The epidemiologic relevance of such disorders justifies the increasing interest in further understanding the mechanisms underpinning the inflammator...

Full description

Bibliographic Details
Main Authors: Marzia Friuli, Barbara Eramo, Marta Valenza, Caterina Scuderi, Gustavo Provensi, Adele Romano
Format: Article
Language:English
Published: MDPI AG 2021-09-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/22/19/10250
_version_ 1797516343378968576
author Marzia Friuli
Barbara Eramo
Marta Valenza
Caterina Scuderi
Gustavo Provensi
Adele Romano
author_facet Marzia Friuli
Barbara Eramo
Marta Valenza
Caterina Scuderi
Gustavo Provensi
Adele Romano
author_sort Marzia Friuli
collection DOAJ
description Unresolved inflammation represents a central feature of different human pathologies including neuropsychiatric, cardiovascular, and metabolic diseases. The epidemiologic relevance of such disorders justifies the increasing interest in further understanding the mechanisms underpinning the inflammatory process occurring in such chronic diseases to provide potential novel pharmacological approaches. The most common and effective therapies for controlling inflammation are glucocorticoids; however, a variety of other molecules have been demonstrated to have an anti-inflammatory potential, including neuropeptides. In recent years, the oxytocinergic system has seen an explosion of scientific studies, demonstrating its potential to contribute to a variety of physiological processes including inflammation. Therefore, the aim of the present review was to understand the role of oxytocin in the modulation of inflammation occurring in different chronic diseases. The criterion we used to select the diseases was based on the emerging literature showing a putative involvement of the oxytocinergic system in inflammatory processes in a variety of pathologies including neurological, gastrointestinal and cardiovascular disorders, diabetes and obesity. The evidence reviewed here supports a beneficial role of oxytocin in the control of both peripheral and central inflammatory response happening in the aforementioned pathologies. Although future studies are necessary to elucidate the mechanistic details underlying such regulation, this review supports the idea that the modulation of the endogenous oxytocinergic system might represent a new potential pharmacological approach for the treatment of inflammation.
first_indexed 2024-03-10T07:00:49Z
format Article
id doaj.art-76c754ebeef24aca94bb6ff508296515
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-03-10T07:00:49Z
publishDate 2021-09-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-76c754ebeef24aca94bb6ff5082965152023-11-22T16:06:39ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672021-09-0122191025010.3390/ijms221910250Targeting the Oxytocinergic System: A Possible Pharmacological Strategy for the Treatment of Inflammation Occurring in Different Chronic DiseasesMarzia Friuli0Barbara Eramo1Marta Valenza2Caterina Scuderi3Gustavo Provensi4Adele Romano5Department of Physiology and Pharmacology “V. Erspamer”, Sapienza University of Rome, 00185 Rome, ItalyDepartment of Physiology and Pharmacology “V. Erspamer”, Sapienza University of Rome, 00185 Rome, ItalyDepartment of Physiology and Pharmacology “V. Erspamer”, Sapienza University of Rome, 00185 Rome, ItalyDepartment of Physiology and Pharmacology “V. Erspamer”, Sapienza University of Rome, 00185 Rome, ItalyDepartment of Neuroscience, Psychology, Drug Research and Child Health (NEUROFARBA), Section of Pharmacology of Toxicology, University of Florence, 50139 Florence, ItalyDepartment of Physiology and Pharmacology “V. Erspamer”, Sapienza University of Rome, 00185 Rome, ItalyUnresolved inflammation represents a central feature of different human pathologies including neuropsychiatric, cardiovascular, and metabolic diseases. The epidemiologic relevance of such disorders justifies the increasing interest in further understanding the mechanisms underpinning the inflammatory process occurring in such chronic diseases to provide potential novel pharmacological approaches. The most common and effective therapies for controlling inflammation are glucocorticoids; however, a variety of other molecules have been demonstrated to have an anti-inflammatory potential, including neuropeptides. In recent years, the oxytocinergic system has seen an explosion of scientific studies, demonstrating its potential to contribute to a variety of physiological processes including inflammation. Therefore, the aim of the present review was to understand the role of oxytocin in the modulation of inflammation occurring in different chronic diseases. The criterion we used to select the diseases was based on the emerging literature showing a putative involvement of the oxytocinergic system in inflammatory processes in a variety of pathologies including neurological, gastrointestinal and cardiovascular disorders, diabetes and obesity. The evidence reviewed here supports a beneficial role of oxytocin in the control of both peripheral and central inflammatory response happening in the aforementioned pathologies. Although future studies are necessary to elucidate the mechanistic details underlying such regulation, this review supports the idea that the modulation of the endogenous oxytocinergic system might represent a new potential pharmacological approach for the treatment of inflammation.https://www.mdpi.com/1422-0067/22/19/10250oxytocininflammationgliachronic diseasestherapeutic strategy
spellingShingle Marzia Friuli
Barbara Eramo
Marta Valenza
Caterina Scuderi
Gustavo Provensi
Adele Romano
Targeting the Oxytocinergic System: A Possible Pharmacological Strategy for the Treatment of Inflammation Occurring in Different Chronic Diseases
International Journal of Molecular Sciences
oxytocin
inflammation
glia
chronic diseases
therapeutic strategy
title Targeting the Oxytocinergic System: A Possible Pharmacological Strategy for the Treatment of Inflammation Occurring in Different Chronic Diseases
title_full Targeting the Oxytocinergic System: A Possible Pharmacological Strategy for the Treatment of Inflammation Occurring in Different Chronic Diseases
title_fullStr Targeting the Oxytocinergic System: A Possible Pharmacological Strategy for the Treatment of Inflammation Occurring in Different Chronic Diseases
title_full_unstemmed Targeting the Oxytocinergic System: A Possible Pharmacological Strategy for the Treatment of Inflammation Occurring in Different Chronic Diseases
title_short Targeting the Oxytocinergic System: A Possible Pharmacological Strategy for the Treatment of Inflammation Occurring in Different Chronic Diseases
title_sort targeting the oxytocinergic system a possible pharmacological strategy for the treatment of inflammation occurring in different chronic diseases
topic oxytocin
inflammation
glia
chronic diseases
therapeutic strategy
url https://www.mdpi.com/1422-0067/22/19/10250
work_keys_str_mv AT marziafriuli targetingtheoxytocinergicsystemapossiblepharmacologicalstrategyforthetreatmentofinflammationoccurringindifferentchronicdiseases
AT barbaraeramo targetingtheoxytocinergicsystemapossiblepharmacologicalstrategyforthetreatmentofinflammationoccurringindifferentchronicdiseases
AT martavalenza targetingtheoxytocinergicsystemapossiblepharmacologicalstrategyforthetreatmentofinflammationoccurringindifferentchronicdiseases
AT caterinascuderi targetingtheoxytocinergicsystemapossiblepharmacologicalstrategyforthetreatmentofinflammationoccurringindifferentchronicdiseases
AT gustavoprovensi targetingtheoxytocinergicsystemapossiblepharmacologicalstrategyforthetreatmentofinflammationoccurringindifferentchronicdiseases
AT adeleromano targetingtheoxytocinergicsystemapossiblepharmacologicalstrategyforthetreatmentofinflammationoccurringindifferentchronicdiseases